Chronic Schizophrenia Clinical Trial
Official title:
To Explore the Experience of Patients With Chronic Schizophrenia Participating in Horticultural Group Therapy
NCT number | NCT05948696 |
Other study ID # | AF007 |
Secondary ID | |
Status | Recruiting |
Phase | |
First received | |
Last updated | |
Start date | June 6, 2023 |
Est. completion date | September 29, 2023 |
Verified date | July 2023 |
Source | TsaoTun Psychiatric Center, Department of Health, Taiwan |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Taiwan National Health Insurance Administration database shows that the number of people seeking medical treatment due to mental illness has reached 1.454 million in 2021. The annual growth rate of mental illness is between 3.3% to 6.6%. Fifty percent of mental illness patient has catastrophic illness certificate because of chronic schizophrenia (Ministry of Health and Welfare,2022). Auditory hallucinations, delusions, emotional disturbances, and disorder in behavior and the poor ability of speaking are common in patients with schizophrenia. These symptoms lead to reduce the cognitive and executive function, resulting severe impairment of eventual daily living functions and social interactions. Thus, the cost of hospitalization and medical fee is increased. It is worth considering the appropriateness of the model of care. According to researches, people with schizophrenia still strive to pursue a happy and satisfying life. However, statistics of satisfaction and happiness are still lower than people who are healthy (Palmer et al., 2014; Fervaha et al., 2016). The American Horticultural Therapy Association (AHTA) pointed out that horticultural therapy increases the well-being of participants through active or passive participation in plant-related activities. It also helps participants learn new skills or regain lost skills. Furthermore, psychiatric symptoms, recovery outcomes, life satisfaction, and the benefits of social function are significantly improved (Lu et al., 2021; Oh et al., 2018). Taiwanese scholars mention that combining horticultural activities and group psychotherapy improves the therapeutic results. It means that using of flowers and plants in gardening combines with the therapeutic advantages of group psychotherapy, mental illness patients can benefit more from it (Lin, 2016). This study aims to explore the experience of patients with chronic schizophrenia participating in horticultural group therapy. This research design adopts the purposive sampling in qualitative method from a psychiatric hospital in central Taiwan. It is expected that 10 participants will involve in 12 times of horticultural therapy, and recordings will be made in each group. After 12 times of the therapy, participants will be involved in semi-structured audio-recorded interviews. The collected data were analyzed step by step using the content analysis method. In addition, participants will finish the questionnaires of the "Mental Well-Being Scale"," Satisfaction With Life Scale ", " activity of daily living Scale ", Instrumental Activities of Daily Living Scale", and "Group Efficacy Observation Form" before and after the therapies. The data will be conducted with descriptive statistics, Pearson's correlation coefficient, Chi-square Test, Paired Sample t test by using SPSS 21.0 statistical software. This research hopes to understand the impact of horticultural treatments in people who suffer from chronic schizophrenia, and provides a reference to clinical teams.
Status | Recruiting |
Enrollment | 10 |
Est. completion date | September 29, 2023 |
Est. primary completion date | September 6, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 20 Years and older |
Eligibility | Inclusion Criteria: - Persons with schizophrenia and have been hospitalized to for more than 6 months. - Intact or minimal cognitive performance on SPMSQ. - Mild to moderate severity on Brief Psychiatric Rating Scale. - ADL score>65 on Barthel Index - Moderate or low on the Warwick-Edinburg Mental Well-being scale Exclusion Criteria: - Those who are not able to comply with the requirements of the study |
Country | Name | City | State |
---|---|---|---|
Taiwan | TsaoTun Psychiatric Center | Nantou |
Lead Sponsor | Collaborator |
---|---|
TsaoTun Psychiatric Center, Department of Health, Taiwan |
Taiwan,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Group Efficacy | Measured by Group Efficacy Observation Form | 12 weeks | |
Primary | Well-being | Measured with the Warwick-Edinburg Mental Well-being scale | 12 weeks | |
Secondary | Basic and instrumental activities of daily living | 12 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00161044 -
An Open-Label Investigation of the Adjuvant Therapeutic Effects of Galantamine in Patients With Chronic Schizophrenia and Persistent Deficit Symptoms
|
N/A | |
Completed |
NCT01450514 -
POC Study of Pipamperone Added to Stable Treatment With RIS or PAL in Chronic Schizophrenia
|
Phase 2 | |
Completed |
NCT05809882 -
Study of Experience of High-frequency Repetitive Transcranial
|
N/A | |
Completed |
NCT06206798 -
Resourcefulness Group Intervention on Recovery and Quality of Life
|
N/A | |
Completed |
NCT01761383 -
Role of Nintendo Wii in Improving Negative Symptoms and Quality of Life in Chronic Schizophrenia
|
N/A | |
Completed |
NCT01891929 -
Cognitive Remediation and Sheltered Employment in Schizophrenia
|
N/A | |
Completed |
NCT03275909 -
Integrated Psychological Therapy for Chronic Schizophrenia
|
N/A | |
Completed |
NCT02298985 -
Curcumin Addition to Antipsychotic Treatment in Chronic Schizophrenia Patients
|
Phase 4 | |
Recruiting |
NCT00525863 -
Oxygen Therapy in Schizophrenia
|
Phase 3 | |
Completed |
NCT02624167 -
A Study to Determine the Safety, Tolerability and Efficacy NW-3509A in Patients With Chronic Schizophrenia
|
Phase 2 | |
Completed |
NCT00789698 -
Lurasidone HCl - A Long Term Phase 3 Study of Patients With Chronic Schizophrenia
|
Phase 3 | |
Recruiting |
NCT06349369 -
Effect of tDCS on Inflammatory Biomarkers in Chronic Schizophrenia
|
N/A | |
Completed |
NCT02421146 -
The Effect of Transcranial Direct Current Stimulation on Human Brains: A Neuroimaging Study
|
N/A | |
Active, not recruiting |
NCT00664274 -
Relation of Catechol-O-methyltransferase (COMT) Genotype and Response to Cognitive Remediation Schizophrenia
|
N/A | |
Terminated |
NCT00148616 -
Memantine for the Treatment of Cognitive Dysfunction and Negative Symptoms in Patients With Chronic Schizophrenia
|
Phase 3 |